1Semenza GL.Targeting HIF-1 for cancer therapy.Nat Rev Cancer,2003,43:721-732.
2Maxwell PH,Dachs GU,Gleadle JM,et al.Hypoxia-inducible factor-1modulates gene exprossion in solid tumors and influences both angiogenesis and tumor growth.Proc Natl Acad Sci USA,1997,94:8104-8109
3Chen D,LI M,Luo J,et al.Direct interactions between HIF-1aplha and mdm2 modulat p53 function.J Biol Chemm,2003,278:13595-13598.
4Sohda M,Ishikawa H,Masuda N,et al.Pretreatment evaluation of combined HIF-1 alpha,p53 and p21 expression is a usful and sensitive indicator of response to radiation and chemotherapy in esophageal cancer.Int J Cancer,2004,110:838-844.
5Kimura S,Kitadai Y,Kuwai T,et al.Expression of p53 protein in esophageal sdquamous cell carcinoma:relation to hypoxia-inducible factor-1 alpha,angiogenesis and apoptosis.Pathobilolgy,2005,72:179-185.
6Ogata Y,Fujita H,Ymaha H,et al.Expression of vascular endothelial growth factor as a prognostic factor in node-positive squamous cell carcinoma in the thoracic esophagus:long-term follow-up study.World J Surg,2003,27:584-589.
7Couvelard A,Paraf F,Gratio V,et al.Angiogenesis in the neoplastic sequence of Barrett's oesophagus.Correlation with VEGF expression.J Pathol,2000,192:14-18.
8Nomiya T,Nemoto K,Miyachi H,et al.Relationships between radiosensitivity and microvascular density in esophageal carcinoma:significance of hypoxic fraction.Int J Radiat Oncol Biol Phys,2004,58:589-596.
9Ogata Y,Harada Y,Fujii T,et al.Immunohistochemical localization of vascular endothelial growth factor in esophageal cancer.Kurume Med J,1996,43:157-163.
10Mobius C,Stein HJ,Becker I,et al.Vascular endothelial growth factor expression and neovascularization in Barrett's carcinoma.World J Surg,2004,28:675-679.
